Company News
Dr Lal PathLabs Invests ₹30.3 Cr in Subsidiary PUPL
Dr Lal PathLabs invested up to ₹30.3 crore in its wholly-owned subsidiary PUPL to fund an acquisition.
The investment enables PUPL to acquire remaining 30% stake in CentraPath Labs, making it a wholly
